Old Web
English
Sign In
Acemap
>
Paper
>
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes.
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes.
2021
Guillermo Garcia-Manero
María Díez-Campelo
Edo Vellenga
Meagan A. Jacoby
Brayan Merchán
Dimitri Breems
Agostino Cortelezzi
Vadim Doronin
Valle Gómez
Marielle M. Beckers
Matteo G. Della Porta
Helen Varsos
Liang Xiu
Nikki A. Deangelis
Ivo P. Nnane
Esther Rose
Koen Van Eygen
Keywords:
transfusion dependence
Internal medicine
Daratumumab
Myelodysplastic syndromes
Medicine
MEDLINE
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
0
Citations
NaN
KQI
[]